Prosperity Financial Group, Inc. Sellas Life Sciences Group, Inc. Transaction History

Prosperity Financial Group, Inc.

  • $179 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$0.51 - $1.55 $12,946 - $39,346
25,385 New
25,385 $25.6 Million
Q3 2023

Nov 07, 2023
SELL
$1.42 - $1.83 $7,100 - $9,150
-5,000 Reduced 16.78%
24,800 $40.7 Million
Q2 2023

Sep 12, 2023
BUY
$1.35 - $1.8 $40,230 - $53,640
29,800 New
29,800 $46.8 Million

Others Institutions Holding SLS

# of Institutions
39
Shares Held
5.69M
Call Options Held
1.67M
Put Options Held
74.7K
View Full List

About SELLAS Life Sciences Group, Inc.

SLS Quotes by TradingView
  • Ticker SLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,551,900
  • Market Cap $19.5M
  • Description
  • SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...
More about SLS
Track This Portfolio

Track Prosperity Financial Group, Inc. Portfolio

Follow Prosperity Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosperity Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Prosperity Financial Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email